Trxade Health (NASDAQ:MEDS) reported its Q1 earnings results on Monday, May 15, 2023 at 04:15 PM.
Here's what investors need to know about the announcement.
Earnings
Trxade Health beat estimated earnings by 25.0%, reporting an EPS of $-0.03 versus an estimate of $-0.04.
Revenue was down $992 thousand from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.04 which was followed by a 20.79% drop in the share price the next day.
Here's a look at Trxade Health's past performance:
| Quarter | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|
| EPS Estimate | -0.06 | -0.12 | -0.08 | -0.11 |
| EPS Actual | -0.10 | -0.06 | -0.13 | -0.12 |
| Revenue Estimate | 2.51M | 3.30M | 2.93M | 2.21M |
| Revenue Actual | 2.53M | 2.40M | 3.28M | 3.24M |
To track all earnings releases for Trxade Health visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
